CTCM Connects Medtech Trailblazers

The MTPConnect Podcast

MTPConnect’s Clinical Translation and Commercialisation Medtech (CTCM) program held its first annual Symposium in Sydney recently, bringing together all 11 companies from around Australia who are recipients of CTCM funding to develop new medical devices to improve health and wellbeing.
In this episode, host Caroline Duell meets some of these Australian trailblazers - Eudaemon Technologies, CathRx, Ventora Medical, LBT Innovations, and 4DMedical, to find out more about their innovations and how the CTCM program is supporting their commercialisation journeys.

You will hear about a next generation hydrogel condom for better contraception and sexual health; a new ablation catheter for treating atrial fibrillation; a contrast-free combined air flow and blood flow 4D lung function scanner; a more accurate airway pressure monitor to detect respiratory distress in newborn babies on breathing support systems; and a compact platform technology to speed up microbiology workflow.

The CTCM program, delivered by MTPConnect, is made possible by the Medical Research Future Fund.